Harnessing the potential of AI in commercial life sciences

Artificial intelligence (AI) has gained significant momentum in life sciences over the past few years.

Bayer chooses UK for its AI-focused R&D hub

UK AI firm Sensyne makes inroads into US health market

The UK clinical artificial intelligence (AI) firm Sensyne has announced agreements with a Fortune 200 company, and a data infrastructure specialist, to launch and grow its digital health pr

Novartis taps Microsoft’s AI expertise for drug development

Novartis has forged an alliance with Microsoft that will apply artificial intelligence and machine-learning to the discovery

Deep Genomics claims AI drug discovery world first

AI therapeutics firm Deep Genomics is claiming a world first after using artificial intelligence to identify a therapeutic drug candidate.

Analysis warns of potentially biased research into AI diagno...

New research has backed the potential of artificial intelligence (AI) as a diagnostic tool, but warned that the patchy nature of available literature may have led to exaggerated claims abou